Tigermed
A contract research company providing whole process clinical trial services for the R&D of pharmaceuticals.
Launch date
Market cap
$5.2b
Enterprise valuation
$5.3b (Public information from Sep 2024)
Share price
HKD27.05 3347.HK
Hangzhou Zhejiang (HQ)
No columns specified